Keywords: lundbeck/merck, co, extend, gaboxadol, deal, danish, drugmaker

Lundbeck/Merck & Co extend gaboxadol deal

Article | 05 July 2004

Danish drugmaker Lundbeck and US major Merck & Co have expanded theirexclusive development and commercialization agreement for the former's insomnia drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Lundbeck

Go to company listing